News

A combination of the antioxidant resveratrol and the multiple sclerosis treatment dimethyl fumarate (DMF) increased the activity of the FXN gene — whose mutation causes Friedreich’s ataxia — in cell and mouse models of the disease, a study showed. Using resveratrol and DMF together also led to improved…

Both clinical severity and frataxin protein levels correlate with the number of disease-causing trinucleotide repeats in the FXN gene of people with Friedreich’s ataxia (FA), with more repeats linked to worse disease. But FA symptoms appear to plateau with anything greater than 700 repeats — after which both clinical…

Children and adults with Friedreich’s ataxia (FA) have lower lean body mass — simply put, the weight of everything in the body except fat — than healthy individuals of about the same age, a study found. Using mice, researchers showed that this loss of lean body mass occurred…

Levels of the protein frataxin, which are abnormally low in people with Friedreich’s ataxia (FA), are further reduced by excess iron and increased protein degradation, a study found. Screening approved compounds in a yeast model identified those that prevented this additional frataxin loss in cells isolated from a patient,…

Children and adolescents with Friedreich’s ataxia (FA) who have an enlarged heart were found to have a high prevalence of irregular heartbeats, and were more likely to have early progression to end-stage disease, according to a nationwide U.K. study. The age of onset and the characteristics of heart enlargement…

The U.S. Food and Drug Administration (FDA) has granted priority review to Reata Pharmaceuticals’ omaveloxolone, an investigational once-daily oral therapy for Friedreich’s ataxia. If approved, omaveloxolone would become the first therapy available for the treatment of the disease in the U.S. The decision comes following the company rounding…

Increased sodium levels were found in regions of the brain commonly affected by Friedreich ataxia (FA) — the cerebellum and brainstem — before structural changes, an MRI imaging study has demonstrated for the first time. The findings showed that increased sodium in these regions was related to an earlier…

Astrocytes, a type of support cell in the brain, showed metabolic defects and unusual pro-inflammatory activity that likely contributes to neuronal dysfunction in a cell model of Friedreich’s ataxia (FA), according to a new study. Results also indicate that treatment with a molecule called smoothened agonist (SAG) can normalize…

Compounds that blocked the activity of histone deacetylases — enzymes that suppress gene activity — increased the activity of the FXN gene, which is low in people with Friedreich’s ataxia (FA) and limits frataxin protein levels, a proof-of-concept study demonstrated. Researchers used nerve cells derived from FA patients to screen…

The annual Friedreich’s Ataxia Awareness Month has commenced to raise disease awareness and honor the 15,000 people living with Friedreich’s ataxia (FA) worldwide. Observed each May, the event seeks to spotlight the rare neuromuscular disease among the public, scientists, health professionals, and lawmakers around the world. “One of the…